JP2025513721A5 - - Google Patents
Info
- Publication number
- JP2025513721A5 JP2025513721A5 JP2024556497A JP2024556497A JP2025513721A5 JP 2025513721 A5 JP2025513721 A5 JP 2025513721A5 JP 2024556497 A JP2024556497 A JP 2024556497A JP 2024556497 A JP2024556497 A JP 2024556497A JP 2025513721 A5 JP2025513721 A5 JP 2025513721A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence selected
- sequences described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323957P | 2022-03-25 | 2022-03-25 | |
| US63/323,957 | 2022-03-25 | ||
| US202263417293P | 2022-10-18 | 2022-10-18 | |
| US63/417,293 | 2022-10-18 | ||
| US202363450602P | 2023-03-07 | 2023-03-07 | |
| US63/450,602 | 2023-03-07 | ||
| PCT/CA2023/050405 WO2023178451A1 (en) | 2022-03-25 | 2023-03-24 | Anti-folate receptor alpha antibodies and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513721A JP2025513721A (ja) | 2025-04-30 |
| JP2025513721A5 true JP2025513721A5 (https=) | 2026-03-31 |
Family
ID=88099476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556497A Pending JP2025513721A (ja) | 2022-03-25 | 2023-03-24 | 抗葉酸受容体アルファ抗体及び使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4499697A4 (https=) |
| JP (1) | JP2025513721A (https=) |
| KR (1) | KR20240162569A (https=) |
| CN (1) | CN119137154A (https=) |
| AU (1) | AU2023237240A1 (https=) |
| CA (1) | CA3245328A1 (https=) |
| MX (1) | MX2024011669A (https=) |
| WO (1) | WO2023178451A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023239448A1 (en) | 2022-03-25 | 2024-11-07 | Zymeworks Bc Inc. | Antibody-drug conjugates targeting folate receptor alpha and methods of use |
| WO2025146173A1 (zh) * | 2024-01-05 | 2025-07-10 | 信达生物制药(苏州)有限公司 | 抗体以及包含其与tlr7/8激动剂的免疫偶联物及其用途 |
| WO2025184730A1 (en) * | 2024-03-04 | 2025-09-12 | Zymeworks Bc Inc. | Antibody constructs binding folate receptor alpha and napi2b, conjugates and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI622402B (zh) * | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| SI2731972T1 (en) * | 2011-07-15 | 2018-04-30 | Eisai R&D Management Co., Ltd. | Anti-folate receptor alpha antibodies and uses thereof |
| US9207238B2 (en) * | 2012-12-07 | 2015-12-08 | Kyowa Hakko Kirin Co., Ltd. | Anti-FOLR1 antibody |
| CN113150145B (zh) * | 2013-08-30 | 2025-02-14 | 伊缪诺金公司 | 用于检测叶酸受体1的抗体和测定 |
-
2023
- 2023-03-24 CN CN202380037567.3A patent/CN119137154A/zh active Pending
- 2023-03-24 EP EP23773420.7A patent/EP4499697A4/en active Pending
- 2023-03-24 JP JP2024556497A patent/JP2025513721A/ja active Pending
- 2023-03-24 CA CA3245328A patent/CA3245328A1/en active Pending
- 2023-03-24 KR KR1020247035214A patent/KR20240162569A/ko active Pending
- 2023-03-24 WO PCT/CA2023/050405 patent/WO2023178451A1/en not_active Ceased
- 2023-03-24 AU AU2023237240A patent/AU2023237240A1/en active Pending
-
2024
- 2024-09-23 MX MX2024011669A patent/MX2024011669A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025513721A5 (https=) | ||
| AU2012235817B2 (en) | Antibody-drug conjugates | |
| CN110770256B (zh) | 靶向axl的抗体及抗体-药物偶联物及其制备方法和用途 | |
| EP4087613A1 (en) | Anti-slc34a2 antibodies, antibody drug conjugates, and methods of use thereof | |
| JP2022510964A5 (https=) | ||
| JP2019146572A5 (https=) | ||
| US20220340673A1 (en) | Antibody targeting bcma, bispecific antibody, and use thereof | |
| CN107735093A (zh) | Cd123抗体和其结合物 | |
| RU2014113304A (ru) | Анти-cd40-антитела, применение и методы | |
| JP2017534253A5 (https=) | ||
| JP2022533418A5 (https=) | ||
| JP2018516539A (ja) | 抗ｃ−Ｍｅｔ抗体および抗ｃ−Ｍｅｔ抗体−細胞毒性薬物複合体ならびにそれらの医薬用途 | |
| JP2022533538A5 (https=) | ||
| JP2017510559A5 (https=) | ||
| CN113195541B (zh) | 针对pmel17的抗体及其缀合物 | |
| JP2024504390A5 (https=) | ||
| EP3545974A1 (en) | Medical use of anti-c met antibody-cytotoxic drug conjugate | |
| JP2021524255A5 (https=) | ||
| TW202245844A (zh) | 抗dll3抗體-藥物結合物 | |
| JP2024533457A5 (https=) | ||
| JP2023546293A5 (https=) | ||
| WO2025157214A1 (zh) | 抗FGFR2b抗体及抗体药物偶联物 | |
| CN112996540A (zh) | 一种c-Met ADC在制备治疗c-Met激酶抑制剂耐药的疾病的药物中的用途 | |
| CN110152014B (zh) | 抗trailr2抗体-毒素-偶联物及其在抗肿瘤治疗中的药物用途 | |
| JP2026512687A (ja) | ヒト化ｌ１ｃａｍ抗体－薬物複合体 |